WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer

January 14, 2018

Responsive image

WUXI, China, Jan. 14, 2018 /PRNewswire/ — WuXi Biologics (WuXi Bio, 02269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to announce that Dr. Chiang Syin has joined…

Category: Precious Metals